Morphine sulphate in intrasite gel (DrugBank: Morphine)
5 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
36 | Epidermolysis bullosa | 1 |
46 | Malignant rheumatoid arthritis | 0 |
70 | Spinal stenosis | 0 |
85 | Idiopathic interstitial pneumonia | 0 |
86 | Pulmonary arterial hypertension | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00231517 (ClinicalTrials.gov) | October 2005 | 3/10/2005 | Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa | Epidermylosis Bullosa | Drug: topical opiod;Drug: morphine sulphate in intrasite gel | Institute of Child Health | NULL | Completed | 4 Years | 18 Years | Both | Phase 4 | United Kingdom |